Lorazepam and Eylea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Eylea (aflibercept). Common drug interactions include dry mouth among females and blindness among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Eylea. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

58 people who take Lorazepam and Eylea together, and have interactions are studied.

What are the common drug interactions of Lorazepam and Eylea, by gender? *:

female:

Dry mouth
Dysphagia (a condition in which swallowing is difficult or painful)
Fall
Foot fracture
Lip swelling
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Neurogenic bowel (impairment of the gastrointestinal and anorectal function from a lesion in the nervous system, resulting in failure to evacuate)
Oral pruritus (itching in mouth)
Rhinorrhoea (watery mucus discharge from the nose)
Visual impairment

male:

Blindness
Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
Congestive cardiomyopathy (weakening of heart muscle)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Death
Eye haemorrhage (bleeding in the eye)
Heart rate decreased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Rhythm idioventricular (a abnormal heart rate)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the common drug interactions of Lorazepam and Eylea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Congestive cardiomyopathy (weakening of heart muscle)
Eye haemorrhage (bleeding in the eye)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

40-49:

Dyskinesia (abnormality or impairment of voluntary movement)
Dyspnoea (difficult or laboured respiration)
Muscle twitching

50-59:

n/a

60+:

Blindness
Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
Visual impairment
Abnormal behaviour
Acute myocardial infarction (acute heart attack)
Age-related macular degeneration
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cerebral disorder (brain disease)
Conjunctivitis (pink eye)

What are the existing conditions these people have? *

Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 12 people, 20.69%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 4 people, 6.90%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.17%
Depression: 3 people, 5.17%
Age-Related Macular Degeneration: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Eylea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously